Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Explore private companies / Fractyl IPO
Fractyl

Fractyl IPO

$872.9MM
Series F Valuation, Jun 2021
Completed IPO
Learn More About Fractyl Stock
Register for details
For more details on financing and valuation of private companies similar to Fractyl before its IPO, register or log in today.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

Fractyl IPO date and status

2010
Founded
Dec 2023
S-1 Filed
www.sec.gov
Feb 2024
IPO Completed
www.reuters.com

Company details

Fractyl ais a biotechnology company looking to bring curative therapies to the large populations of patients with metabolic disease. Fractyl was founded in 2010 by Harith Rajagopalan and is headquartered in Burlington, MA.
fractyl.com
Sector
Healthcare
Subsector
Biotech & Pharma
Founded
2010
Headquarters
Burlington, MA, United States
Forge Price 1
Price not available
Market Activity 2
Limited
Last Matched Price
Get Full Access
Post-Money Valuation 3
$872.9MM
Total Funding
$572.96MM
Last Funding Round
Series F

Learn more about Fractyl

To invest in Fractyl pre-IPO

Can you invest in Fractyl pre-IPO?

You may invest in Fractyl as it is a public company listed on the NASDAQ with ticker GUTS. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of Fractyl before it goes public?

You can no longer sell shares of Fractyl on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my Fractyl shares?

Forge can no longer determine the value of Fractyl shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is Fractyl a publicly traded company?

Fractyl became a public company following its IPO on 02/02/2024 and is now traded on the NASDAQ under the ticker GUTS.

To learn more about Fractyl potential IPO

Will Fractyl go IPO?

Fractyl became a public company following its IPO on 02/02/2024 and is now traded on the NASDAQ under the ticker GUTS.

What is Fractyl’s IPO price?

The IPO price of Fractyl is not currently available.

When was Fractyl founded?

Fractyl was founded in 2010.

What is Fractyl funding to date?

Fractyl has raised $572.96MM to date.

Fractyl pre-IPO valuation and funding rounds

Funding history chart
Funding round and deals details
Funding Date Round Amount Raised Price per Share Post-Money Valuation 3 Key Investors
06/16/2021 Series F $100MM $8.38 $872.9MM M28 Capital, Maverick Capital, Population Health Partners
Price per Share
$ xx.xx
Shares Outstanding
11,927,048
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
M28 Capital, Maverick Capital, Population Health Partners
08/06/2020 Series E $55.07MM $4.29 $378.52MM Bessemer Venture Partners, Catalio Capital Management, Cdib Venture Capital, Domain Associates, Emergent Medical Partners, General Catalyst, Google Ventures, Mithril Capital Management, Taiwania Capital Management Corporation, True Ventures, Yj Capital
Price per Share
$ xx.xx
Shares Outstanding
12,838,573
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Catalio Capital Management, Cdib Venture Capital, Domain Associates, Emergent Medical Partners, General Catalyst, Google Ventures, Mithril Capital Management, Taiwania Capital Management Corporation, True Ventures, Yj Capital
11/30/2017 Series D $43.98MM $3.67 $260.81MM Bessemer Venture Partners, Deerfield Management Company, Domain Associates, Emergent Medical Partners, General Catalyst, Google Ventures, Ido Fund, Mithril Capital Management, True Ventures
Price per Share
$ xx.xx
Shares Outstanding
11,994,461
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Deerfield Management Company, Domain Associates, Emergent Medical Partners, General Catalyst, Google Ventures, Ido Fund, Mithril Capital Management, True Ventures
11/19/2015 Series C-2 $47.17MM $3.08 $169.58MM Bessemer Venture Partners, Deerfield Management Company, Domain Associates, General Catalyst, Mithril
Price per Share
$ xx.xx
Shares Outstanding
15,336,464
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Deerfield Management Company, Domain Associates, General Catalyst, Mithril
11/19/2015 Series C-1 $20.26MM $2.24 $169.58MM Bessemer Venture Partners, Deerfield Management Company, Domain Associates, General Catalyst, Mithril
Price per Share
$ xx.xx
Shares Outstanding
9,064,640
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Deerfield Management Company, Domain Associates, General Catalyst, Mithril
03/21/2013 Series B $14.5MM $1.27 $28.61MM Undisclosed Investors
Price per Share
$ xx.xx
Shares Outstanding
11,451,453
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
06/15/2011 Series A $5.5MM $1.00 $11MM Undisclosed Investors
Price per Share
$ xx.xx
Shares Outstanding
5,500,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors

Fractyl IPO news and media highlights

FierceBiotech 01/29/2024

Fractyl Sets Out $99M IPO Ambitions After Busy Week of Biotechs Going Public

Fractyl Health, a biotechnology startup that focuses on preventing and curing metabolic diseases, announced in December 2023 that an initial public offering (IPO) may happen for the company. The company is sticking to that plan by selling 7.3 million shares for $14 to $16 each to add $99 million in capital. Fractyl Health has tested its Rejuva gene therapy candidate, which is a treatment that may compete with semaglutide drug Wegovy from pharmaceutical researcher Novo Nordisk.
Seeking Alpha 12/17/2023

Fractyl Health Aims For $100 Million IPO Raise

Fractyl Health, which is a startup that designs medical therapies for metabolic health, filed with the SEC to raise $100 million through an initial public offering (IPO). Specifically, the Lexington, Massachusetts-based company is working to treat Type 2 Diabetes as well as obesity in patients, and Fractyl Health will use the IPO capital to complete its Revitalize-1 research, fund the Remain-1 study and development of Rejuva gene therapy candidates, and prepare for commercialization of its therapies.
FinSMEs 11/30/2017

Fractyl Completes $44M Series D Financing |FinSMEs

Fractyl Laboratories Inc., a Lexington, Mass.-based developer of minimally invasive procedural therapy that can reverse metabolic diseases, completed a $44m Series D financing. The round was led by an undisclosed new investor, joined by new investors GV, True Ventures, and the IDO Fund and returning investors General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital …
Browse More Insights

Private companies exploring an IPO

See which private companies are preparing for the public market. Register to get full access to the latest secondary market pricing data.

Sector: Healthcare
Subsector: Biotech & Pharma
Trade Metrics Last Funding Round
Company Forge Price Last Matched Round Post-Money Valuation 3 Price Per Share Amount Raised
Generate BiomedicinesGenerate BiomedicinesNot available$ xx.xxSeries C$1.95B$11.85$288MM
Spyglass PharmaSpyglass PharmaNot available$ xx.xxSeries D$350.04MM$2.33$75MM
Affinia TherapeuticsAffinia TherapeuticsNot available$ xx.xxSeries C$156.61MM$1.62$40MM
OriginOriginNot available$ xx.xxNot available------
See Tech IPO Calendar

Private market movers

Track trading activity and investor momentum across thousands of private companies. Register to view last matched prices and additional transactional details.

Actively traded

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
SpaceX SpaceX $550.00 +$102.77 (22.98%)High $xxx.xx
Anduril Anduril $114.78 +$9.78 (9.31%)High $xxx.xx
Databricks Databricks $197.72 +$0.06 (0.03%)High $xxx.xx
See All Actively Traded Companies

Artificial Intelligence (AI)

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
Anduril Anduril $114.78 +$9.78 (9.31%)High $xxx.xx
Databricks Databricks $197.72 +$0.06 (0.03%)High $xxx.xx
Figure AI Figure AI $174.00 -$20.00 (10.31%)Limited $xxx.xx
See All AI Companies

Forge, your trusted partner for pre-IPO insights and Fractyl data

Forge is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Register

Updated on: Jul 16, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions on Forge.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. Actively traded companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.